- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prevention of Infection With HIV-1 in Korea, Republic of
Total 110 results
-
SL VAXiGENSL BIGENUnknownBK Virus Infection | Cytomegalovirus Infections | Preventation of Cytomegalovirus Reactivation | Preventation of BK Virus ReactivationKorea, Republic of
-
Bristol-Myers SquibbCompleted
-
Asan Medical CenterCompletedNon-HIV Patients With Pneumocystis Jiroveci PneumoniaKorea, Republic of
-
SK Chemicals Co., Ltd.CompletedPrevention of InfluenzaKorea, Republic of
-
Uijeongbu St. Mary HospitalUnknownProportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48Korea, Republic of
-
CONRADCompletedHIV PreventionDominican Republic, United States
-
Hyundai PharmCompletedEvaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic BronchitisKorea, Republic of
-
Seoul National University HospitalRecruitingBronchiectasis | Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Airway Disease | Asthma With Chronic Obstructive Pulmonary Disease | Inactive Tuberculosis of LungKorea, Republic of
-
ViriomCompletedHIV-1-infectionRussian Federation
-
Gilead SciencesCompletedHIV-1/HBV Co-InfectionSpain, Taiwan, Korea, Republic of, Thailand, Hong Kong, Japan, France, Turkey, Puerto Rico, Malaysia, United States, China, Dominican Republic, Greece
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States
-
Gilead SciencesCompletedHIV-1-infectionUnited States, Dominican Republic, Puerto Rico, Thailand
-
Gilead SciencesActive, not recruitingPre-Exposure Prophylaxis of HIV-1 InfectionUnited States, Austria, Denmark, United Kingdom, Netherlands, Italy, Germany, Canada, Ireland, France, Spain
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States, Puerto Rico
-
Gilead SciencesCompletedHIV-1 InfectionRussian Federation, United States, Thailand, Uganda, Puerto Rico, Dominican Republic
-
Gilead SciencesCompleted
-
Gilead SciencesCompleted
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States, Puerto Rico, Thailand
-
University of PennsylvaniaCompletedHIV-1 InfectionsUnited States
-
Gilead SciencesCompleted
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States
-
Gilead SciencesActive, not recruitingHIV-1-infectionUnited States, Spain, France, Taiwan, Japan, Thailand, Dominican Republic, Germany, Canada, Italy, South Africa
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United Kingdom, France, Germany, United States, Italy
-
Merck Sharp & Dohme LLCCompletedHIV-1 InfectionUnited States, Chile, France, United Kingdom
-
Tobira Therapeutics, Inc.Completed
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States, Puerto Rico
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, Italy, Germany, United Kingdom, France, Australia, Puerto Rico, Canada, Belgium, Dominican Republic
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States, Puerto Rico
-
Gilead SciencesCompletedHIV-1 InfectionFrance, Spain, Germany, United Kingdom, United States, Puerto Rico, Belgium, Canada, Italy, Dominican Republic
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, France, Germany, United Kingdom, Italy, Canada, Australia, Belgium, Puerto Rico, Dominican Republic
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States, Puerto Rico
-
Janssen R&D IrelandCompletedHIV-1 InfectionUnited States, Australia, France, United Kingdom, China, Belgium, Germany, Spain, Argentina, Romania, South Africa, Canada, Denmark, Netherlands, Chile, Puerto Rico, Austria, Russian Federation, Thailand, Sweden, Taiwan
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United Kingdom, Sweden, Germany, United States, France, Belgium, Ireland, Italy, Denmark, Puerto Rico, Canada
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, United Kingdom, Canada, France, Italy, Puerto Rico, Belgium
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, France, Italy, Germany, Canada, United Kingdom, Belgium, Puerto Rico, Australia
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, Spain, United Kingdom, Canada, Puerto Rico, France, Belgium, Italy, Germany, Austria
-
Gilead SciencesRecruitingHIV-1-infectionJapan, Germany, France, United States, Spain, Korea, Republic of, South Africa, Australia, Argentina, Canada, Dominican Republic, Italy, Puerto Rico, Taiwan, United Kingdom
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, Spain, United Kingdom, Netherlands, Germany, Canada, Sweden, Switzerland, Italy, Belgium, Puerto Rico, France
-
Gilead SciencesCompletedHIV-1-infectionUnited States, Puerto Rico, France, Germany, Austria, Canada
-
Merck Sharp & Dohme LLCCompletedHIV-1 InfectionUnited States, Australia, Canada, Chile, Colombia, France, Germany, Italy, Japan, Korea, Republic of, Peru, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
-
Gilead SciencesRecruitingHIV-1-infectionUnited States, Thailand, Dominican Republic
-
Gilead SciencesCompletedHIV-1 InfectionCanada, United States, Puerto Rico, Spain, United Kingdom, France, Portugal, Netherlands, Belgium, Italy, Australia, Austria, Germany, Switzerland
-
Gilead SciencesCompletedHIV-1 InfectionSpain, United States, United Kingdom, Switzerland, Germany, Canada, France, Belgium, Puerto Rico
-
Tehran University of Medical SciencesRojanPharma Pharmaceutical CompanyCompletedHuman Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy ofIran, Islamic Republic of
-
Merck Sharp & Dohme LLCCompletedHIV-1 InfectionUnited States, Italy, Russian Federation, South Africa, Thailand
-
Gilead SciencesCompletedHIV-1 Infection | HCV InfectionUnited States, Puerto Rico